Goldman Sachs Upgrades Mindray Medical (MR) to Buy on Recent Underperformance
Tweet Send to a Friend
Goldman Sachs upgraded Mindray Medical (NYSE: MR) from Neutral to Buy with a price target of $39.60.
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
